Joey Mattingly (@joeymattingly) 's Twitter Profile
Joey Mattingly

@joeymattingly

Associate Professor, University of Utah; Research interests include health economics of infectious diseases and patient-centered outcomes research.

ID: 34101083

linkhttps://pharmacy.utah.edu/joey-mattingly calendar_today22-04-2009 00:03:41

11,11K Tweet

3,3K Followers

1,1K Following

Adam J. Fein (@drugchannels) 's Twitter Profile Photo

๐Ÿ” ๐ˆ๐ง๐ญ๐ซ๐ข๐ ๐ฎ๐ข๐ง๐  ๐๐ž๐ฐ ๐ƒ๐š๐ญ๐š ๐จ๐ง ๐‘๐ž๐ญ๐š๐ข๐ฅ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ (2010โ€“2023) Fresh insights from a new analysis of U.S. #pharmacy openings and closures: โ€ข Chain Pharmacies: From 2010 to 2015, total chain locations grew. But since 2016, closures have

๐Ÿ” ๐ˆ๐ง๐ญ๐ซ๐ข๐ ๐ฎ๐ข๐ง๐  ๐๐ž๐ฐ ๐ƒ๐š๐ญ๐š ๐จ๐ง ๐‘๐ž๐ญ๐š๐ข๐ฅ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐ƒ๐ฒ๐ง๐š๐ฆ๐ข๐œ๐ฌ (2010โ€“2023)

Fresh insights from a new analysis of U.S. #pharmacy openings and closures:

โ€ข Chain Pharmacies: From 2010 to 2015, total chain locations grew. But since 2016, closures have
Joey Mattingly (@joeymattingly) 's Twitter Profile Photo

I donโ€™t mind using both โ€œcarrotsโ€ & โ€œsticksโ€ when it comes to incentivizing domestic manufacturing of *some* pharmaceuticals, but Iโ€™m not sure this should be a blanket approach for all products.

JAMA Health Forum (@jamahealthforum) 's Twitter Profile Photo

Between 2010 and 2023, the US community pharmacy market experienced a 6.2% annual turnover rate, with independent pharmacies having higher turnover than chains. ja.ma/4muD7lY Joey Mattingly Kelly Anderson

Between 2010 and 2023, the US community pharmacy market experienced a 6.2% annual turnover rate, with independent pharmacies having higher turnover than chains. 

ja.ma/4muD7lY 

<a href="/joeymattingly/">Joey Mattingly</a> <a href="/KellyAnders0n/">Kelly Anderson</a>
Joey Mattingly (@joeymattingly) 's Twitter Profile Photo

Can someone apolitical explain how this is going to change things? The NIH grant funding process has always been interesting (and confusing) to me both as a researcher & study section reviewer.